Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1186-1189

  Kim, Young S ^a,b   Liu, Quingxiang ^a,b   Chow, Lucien L ^a,b   Täuber, Martin G ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Institute for Medical Microbiology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALATROFLOXACIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN BINDING PROTEIN; PENICILLIN G; PRODRUG; RIFAMPICIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS PNEUMONIAE;

EID: 0030940112     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1186     Document Type: Article

References (26)

1. Barnes, D. M., S. Whittier, P. H. Gilligan, S. Soares, A. Tomasz, and F. W. Henderson. 1995. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J. Infect. Dis. 171:890-896.
2. Bayer, A. S., C. Li, E. Kim, and M. Ing. 1996. Efficacy of trovafloxacin (CP-99219) in the therapy of experimental endocarditis due to drug-resistant enterococci, abstr. B2, p. 21. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Beam, T. R. 1981. Vancomycin therapy of experimental pneumococcal meningitis caused by penicillin sensitive and resistant strains. J. Antimicrob. Chemother. 7:89-99.
4. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliot, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
5. Dacey, R. G., and M. A. Sande. 1974. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob. Agents Chemother. 6:437-441.
6. Dalhoff, A. 1989. A review of tissue pharmacokinetics, p. 277-312. In P. Fernandez (ed.), Quinolones. J. R. Prous Scientific Publisher, Barcelona, Spain.
7. Doit, C. P., S. P. Bonacorsi, A. J. Fremaux, G. Sissia, R. Cohen, P. L. Geslin, and E. H. Bingen. 1994. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis. Antimicrob. Agents Chemother. 38:2655-2659.
8. Friedland, I. R., M. Paris, S. Ehrett, S. Hickey, K. Olsen, and G. H. McCracken, Jr. 1993. Evaluation of antimicrobial regimens for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 37:1630-1636.
9. Girard, A. E., D. Girard, T. D. Gootz, J. A. Faiella, and C. R. Cimochowski. 1995. In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis. Antimicrob. Agents Chemother. 39:2210-2216.
10. Gootz, T. D., and P. R. McGuirk. 1994. New quinolones in development. Expert Opin. Invest. Drugs 3:93-114.
11. John, C. C. 1994. Treatment failure with use of a third generation cephalosporin for penicillin resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 18:188-193.
12. Klugman, K. P., and H. J. Koornhof. 1989. Worldwide increase in pneumococcal antibiotic resistance. Lancet ii:444.
13. McCracken, G. H., Jr., and Y. Sakata. 1985. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrob. Agents Chemother. 27:141-145.
14. Munoz, R., T. J. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306.
15. Nan, R., K. Kaye, M. Sachdeva, E. R. Sande, and M. G. Täuber. 1994. Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrob. Agents Chemother. 38:1186-1189.
16. Nau, R., T. Schmidt, K. Kaye, J. L. Froula, and M. G. Täuber. 1995. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits. Antimicrob. Agents Chemother. 39:593-597.
17. París, M. M., S. M. Hickey, M. Trujillo, S. Shelton, and G. H. McCracken, Jr. 1995. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 39:1243-1246.
18. París, M. M., O. Ramilo, and G. H. McCracken, Jr. 1995. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:2171-2175.
19. Pfizer Inc. 1996. Manufacturer's information. Pfizer Inc., New York, N.Y.
20. Scheld, W. M. 1989. Quinolone therapy for infections of the central nervous system. Rev. Infect. Dis. 11(Suppl. 5):S1194-S1202.
21. Schlech, W. F., J. I. Ward, J. D. Band, A. Hightower, D. W. Fraser, and C. V. Broome. 1985. Bacterial meningitis in the United States, 1978 through 1981. JAMA 253:1749-1754.
22. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1992. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36: 856-859.
23. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1993. Comparative activity of the new quinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococci. Eur. J. Clin. Microbiol. Infect. Dis. 12:965-967.
24. Täuber, M. G., C. A. Doroshow, C. J. Hackbarth, M. G. Rusnak, T. A. Drake, and M. A. Sande. 1984. Antibacterial activity of β-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J. Infect. Dis. 149: 568-574.
25. Täuber, M. G., S. Kunz, O. Zak, and M. A. Sande. 1989. Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits. Antimicrob. Agents Chemother. 33:418-423.
26. Viladrich, P. F., F. Gudiol, J. Liñares, R. Pallarés, I. Sabaté, G. Rufi, and J. Ariza. 1991. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob. Agents Chemother. 35:2467-2472.